Logo image of LEG.DE

LEG IMMOBILIEN SE (LEG.DE) Stock Fundamental Analysis

FRA:LEG - Deutsche Boerse Ag - DE000LEG1110 - Common Stock - Currency: EUR

80.44  +2.18 (+2.79%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LEG. LEG was compared to 71 industry peers in the Real Estate Management & Development industry. LEG has a medium profitability rating, but doesn't score so well on its financial health evaluation. LEG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year LEG was profitable.
LEG had a positive operating cash flow in the past year.
Of the past 5 years LEG 4 years were profitable.
Each year in the past 5 years LEG had a positive operating cash flow.
LEG.DE Yearly Net Income VS EBIT VS OCF VS FCFLEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

1.2 Ratios

LEG has a Return On Assets (-2.98%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -8.03%, LEG is doing worse than 62.50% of the companies in the same industry.
LEG has a Return On Invested Capital of 1.50%. This is comparable to the rest of the industry: LEG outperforms 50.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LEG is below the industry average of 4.27%.
The 3 year average ROIC (1.33%) for LEG is below the current ROIC(1.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.98%
ROE -8.03%
ROIC 1.5%
ROA(3y)0.44%
ROA(5y)3.31%
ROE(3y)0.28%
ROE(5y)6.63%
ROIC(3y)1.33%
ROIC(5y)1.4%
LEG.DE Yearly ROA, ROE, ROICLEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

Looking at the Operating Margin, with a value of 44.13%, LEG is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
In the last couple of years the Operating Margin of LEG has declined.
LEG has a Gross Margin (47.60%) which is comparable to the rest of the industry.
LEG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.13%
PM (TTM) N/A
GM 47.6%
OM growth 3Y-3.91%
OM growth 5Y-2.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-3.02%
LEG.DE Yearly Profit, Operating, Gross MarginsLEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

1

2. Health

2.1 Basic Checks

LEG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LEG remains at a similar level compared to 1 year ago.
The number of shares outstanding for LEG has been increased compared to 5 years ago.
Compared to 1 year ago, LEG has a worse debt to assets ratio.
LEG.DE Yearly Shares OutstandingLEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
LEG.DE Yearly Total Debt VS Total AssetsLEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.79, we must say that LEG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.79, LEG is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
The Debt to FCF ratio of LEG is 23.80, which is on the high side as it means it would take LEG, 23.80 years of fcf income to pay off all of its debts.
LEG's Debt to FCF ratio of 23.80 is fine compared to the rest of the industry. LEG outperforms 62.50% of its industry peers.
A Debt/Equity ratio of 1.09 is on the high side and indicates that LEG has dependencies on debt financing.
With a Debt to Equity ratio value of 1.09, LEG is not doing good in the industry: 69.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 23.8
Altman-Z 0.79
ROIC/WACC0.49
WACC3.04%
LEG.DE Yearly LT Debt VS Equity VS FCFLEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.3 Liquidity

LEG has a Current Ratio of 0.48. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
LEG has a Current ratio of 0.48. This is amonst the worse of the industry: LEG underperforms 83.93% of its industry peers.
LEG has a Quick Ratio of 0.48. This is a bad value and indicates that LEG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.47, LEG is not doing good in the industry: 69.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.47
LEG.DE Yearly Current Assets VS Current LiabilitesLEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

4

3. Growth

3.1 Past

LEG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.55%, which is quite impressive.
The Earnings Per Share has been growing slightly by 5.59% on average over the past years.
Looking at the last year, LEG shows a small growth in Revenue. The Revenue has grown by 3.41% in the last year.
LEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.10% yearly.
EPS 1Y (TTM)52.55%
EPS 3Y-4.23%
EPS 5Y5.59%
EPS Q2Q%-23.36%
Revenue 1Y (TTM)3.41%
Revenue growth 3Y12.97%
Revenue growth 5Y10.1%
Sales Q2Q%3.2%

3.2 Future

Based on estimates for the next years, LEG will show a small growth in Earnings Per Share. The EPS will grow by 2.68% on average per year.
LEG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.26% yearly.
EPS Next Y5.93%
EPS Next 2Y3.38%
EPS Next 3Y2.68%
EPS Next 5YN/A
Revenue Next Year-4.68%
Revenue Next 2Y-1.29%
Revenue Next 3Y-0.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LEG.DE Yearly Revenue VS EstimatesLEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
LEG.DE Yearly EPS VS EstimatesLEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

LEG is valuated correctly with a Price/Earnings ratio of 16.79.
Compared to the rest of the industry, the Price/Earnings ratio of LEG indicates a somewhat cheap valuation: LEG is cheaper than 69.64% of the companies listed in the same industry.
LEG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.47.
A Price/Forward Earnings ratio of 13.37 indicates a correct valuation of LEG.
Based on the Price/Forward Earnings ratio, LEG is valued a bit cheaper than 64.29% of the companies in the same industry.
LEG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE 16.79
Fwd PE 13.37
LEG.DE Price Earnings VS Forward Price EarningsLEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

LEG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LEG is cheaper than 60.71% of the companies in the same industry.
64.29% of the companies in the same industry are more expensive than LEG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.55
EV/EBITDA 26.43
LEG.DE Per share dataLEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LEG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.83
PEG (5Y)3.01
EPS Next 2Y3.38%
EPS Next 3Y2.68%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.10%, LEG has a reasonable but not impressive dividend return.
LEG's Dividend Yield is a higher than the industry average which is at 7.48.
LEG's Dividend Yield is a higher than the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 3.1%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LEG.DE Yearly Dividends per shareLEG.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 2 4 6

5.3 Sustainability

The earnings of LEG are negative and hence is the payout ratio. LEG will probably not be able to sustain this dividend level.
DP-26.07%
EPS Next 2Y3.38%
EPS Next 3Y2.68%
LEG.DE Yearly Income VS Free CF VS DividendLEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

LEG IMMOBILIEN SE

FRA:LEG (2/5/2025, 4:46:08 PM)

80.44

+2.18 (+2.79%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners72.4%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.99B
Analysts75
Price Target100.69 (25.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.1%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-26.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.8%
Min EPS beat(2)-32.58%
Max EPS beat(2)-9.03%
EPS beat(4)1
Avg EPS beat(4)-10.15%
Min EPS beat(4)-32.58%
Max EPS beat(4)30.12%
EPS beat(8)1
Avg EPS beat(8)-29.9%
EPS beat(12)2
Avg EPS beat(12)-49.29%
EPS beat(16)3
Avg EPS beat(16)-31.64%
Revenue beat(2)1
Avg Revenue beat(2)16.12%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)37.97%
Revenue beat(4)2
Avg Revenue beat(4)16.94%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)42.79%
Revenue beat(8)4
Avg Revenue beat(8)11.64%
Revenue beat(12)8
Avg Revenue beat(12)21.27%
Revenue beat(16)12
Avg Revenue beat(16)20.24%
PT rev (1m)0.52%
PT rev (3m)3.77%
EPS NQ rev (1m)4.9%
EPS NQ rev (3m)15%
EPS NY rev (1m)1.47%
EPS NY rev (3m)1.47%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)-3.57%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE 16.79
Fwd PE 13.37
P/S 4.73
P/FCF 14.55
P/OCF 14
P/B 0.82
P/tB 0.82
EV/EBITDA 26.43
EPS(TTM)4.79
EY5.95%
EPS(NY)6.02
Fwd EY7.48%
FCF(TTM)5.53
FCFY6.87%
OCF(TTM)5.74
OCFY7.14%
SpS17
BVpS98.21
TBVpS98.16
PEG (NY)2.83
PEG (5Y)3.01
Profitability
Industry RankSector Rank
ROA -2.98%
ROE -8.03%
ROCE 3.21%
ROIC 1.5%
ROICexc 1.54%
ROICexgc 1.54%
OM 44.13%
PM (TTM) N/A
GM 47.6%
FCFM 32.53%
ROA(3y)0.44%
ROA(5y)3.31%
ROE(3y)0.28%
ROE(5y)6.63%
ROIC(3y)1.33%
ROIC(5y)1.4%
ROICexc(3y)1.36%
ROICexc(5y)1.43%
ROICexgc(3y)1.37%
ROICexgc(5y)1.44%
ROCE(3y)2.84%
ROCE(5y)2.99%
ROICexcg growth 3Y-0.67%
ROICexcg growth 5Y-4.46%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y-4.3%
OM growth 3Y-3.91%
OM growth 5Y-2.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.37%
GM growth 5Y-3.02%
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 23.8
Debt/EBITDA 13.89
Cap/Depr 105.96%
Cap/Sales 1.26%
Interest Coverage 3.55
Cash Conversion 74.57%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.47
Altman-Z 0.79
F-Score6
WACC3.04%
ROIC/WACC0.49
Cap/Depr(3y)59.11%
Cap/Depr(5y)51.14%
Cap/Sales(3y)3.07%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.55%
EPS 3Y-4.23%
EPS 5Y5.59%
EPS Q2Q%-23.36%
EPS Next Y5.93%
EPS Next 2Y3.38%
EPS Next 3Y2.68%
EPS Next 5YN/A
Revenue 1Y (TTM)3.41%
Revenue growth 3Y12.97%
Revenue growth 5Y10.1%
Sales Q2Q%3.2%
Revenue Next Year-4.68%
Revenue Next 2Y-1.29%
Revenue Next 3Y-0.26%
Revenue Next 5YN/A
EBIT growth 1Y-2.43%
EBIT growth 3Y8.54%
EBIT growth 5Y7.84%
EBIT Next Year60.22%
EBIT Next 3Y20.31%
EBIT Next 5YN/A
FCF growth 1Y46.24%
FCF growth 3Y11.67%
FCF growth 5Y8.96%
OCF growth 1Y20.37%
OCF growth 3Y11.16%
OCF growth 5Y9.19%